Reflecting on Africa's successes, challenges in fight against malaria

NewsGuard 100/100 Score

Ellen Johnson Sirleaf, president of Liberia and the new chair of the African Leaders Malaria Alliance (ALMA), writes in a Huffington Post opinion piece about Africa's efforts in the fight against malaria. "Supported by the lessons learned from the decade to 'roll back malaria,' which produced a 33 percent decline in malaria deaths in Africa between 2000 and 2010, 41 African presidents have now signed on to end deaths from the disease in their home countries as part of [ALMA]," she writes. But "[d]espite this encouraging progress, much work remains to be done," she continues. 

Citing ways malaria affects health and education outcomes, Sirleaf says that "to understand malaria's true impact, consider that the disease can rob individual families in poorer communities of as much as 25 percent of their disposable income. By controlling malaria we eliminate a major obstacle to sustainable economic development and stability in Africa." She adds, "…[W]ith sound policies, genuine leadership, and reliable partnership from the world, I believe Africa can be free of the need for development assistance in a generation" (1/29).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    WHO recommends R21/Matrix-M vaccine for malaria prevention in children